Get started
Author

Yukihisa Hatakeyama

Observed names: Hatakeyama Yukihisa, Hatakeyama, Yukihisa, Y. Hatakeyama
ORCID: 0000-0002-3291-0637
Observed ORCID: 0000-0002-3291-0637
OpenAlex ID: A5025624036
A metabolomic approach to lung cancer
2011 · Suya Hori, Shin Nishiumi, et al. · Lung Cancer · 207
Synergistic effects of pemetrexed and amrubicin in non-small cell lung cancer cell lines: Potential for combination therapy
2013 · Yukihisa Hatakeyama, Kazuyuki Kobayashi, et al. · Cancer Letters · 21
PDF
Bronchoscopy Using Virtual Navigation and Endobronchial Ultrasonography with a Guide Sheath (EBUS-GS) with or without Fluoroscopy for Peripheral Pulmonary Lesions.
2018 · Motoko Tachihara, Daisuke Tamura, et al. · Europe PMC (PubMed Central) · 20
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · Heliyon · 11
Long-term Outcome after Multidisciplinary Approach for Leptomeningeal Carcinomatosis in a Non-small Cell Lung Cancer Patient with Poor Performance Status
2011 · Tatsuya Nagano, Yoshikazu Kotani, et al. · Internal Medicine · 11
PDF
Fatal Hemoptysis Due to Endobronchial Aspergilloma in the Hyperinflated Native Lung after Single-Lung Transplantation for Lymphangioleiomyomatosis: A Case Report.
2020 · Asuka Yoshizaki, Masatsugu Yamamoto, et al. · PubMed · 10
Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report
2018 · Yukihisa Hatakeyama, Hisashi Ohnishi, et al. · Journal of Oncology Pharmacy Practice · 10
TAPO in first‐line osimertinib therapy and continuation of osimertinib
2022 · Chihiro Mimura, Kazumi Kaneshiro, et al. · Thoracic Cancer · 7
PDF
Primary pleural synovial sarcoma with repeated resection leading to long‐term survival
2019 · Naoko Katsurada, Hisashi Ohnishi, et al. · Respirology Case Reports · 7
PDF
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
2019 · Motoko Tachihara, Tatsunori Kiriu, et al. · Cancer Management and Research · 6
PDF
Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
2011 · Tatsuya Nagano, Yoshikazu Kotani, et al. · Case Reports in Pulmonology · 6
PDF
Surgical repair of hepatic hydrothorax caused by diaphragmatic fistula
2020 · Miho Ikeda, Yukihisa Hatakeyama, et al. · Respiratory Medicine Case Reports · 5
PDF
Endobronchial metastases 20 years after prostate cancer excision
2019 · Yukihisa Hatakeyama, Sho Yoshimura, et al. · Respiratory Medicine Case Reports · 5
PDF
Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung Adenocarcinoma
2025 · Jun Yamada, Naoe Jimbo, et al. · Cancer Management and Research · 4
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
2020 · Naoko Katsurada, Motoko Tachihara, et al. · Cancer Management and Research · 4
PDF
Unicentric Castleman's Disease of Paraspinal Origin Requiring Differentiation From Schwannoma: Case Report
2025 · Hazuki Fujimoto, Kayoko Okamura, et al. · Respirology Case Reports · 3
PDF
Drug-Induced Interstitial Lung Disease after Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer
2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · SSRN Electronic Journal · 1
Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy.
2026 · Natsuhiko Iwamoto, Jun Yamada, et al. · PubMed
1474P Outcome of nivolumab and ipilimumab-based therapy for advanced non-small cell lung cancer with low or negative PD-L1 expression
2023 · T. Fukui, S. Hori, et al. · Annals of Oncology
PDF
Drug-Induced Interstitial Lung Disease after Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer
2023 · Kiyoko Fukuda, Naoko Katsurada, et al. · SSRN Electronic Journal
1141P A multicenter study of incidence of drug-induced lung disease in first-line osimertinib therapy and continuation of osimertinib administration
2022 · C. Mimura, M. Tachihara, et al. · Annals of Oncology
Steroid-Sparing Effect, Effectiveness, and Tolerability of Mepolizumab with EGPA in Real World Clinical Practice
2021 · Yukihisa Hatakeyama, Rei Tsukamoto, et al. · Research Square
PDF
EGPAdetabase update.xlsx
2021 · Hatakeyama, Yukihisa, Tsukamoto, Rei, et al. · Figshare
P2.17-05 Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
2019 · N. Katsurada, M. Tachihara, et al. · Journal of Thoracic Oncology
前立腺癌切除後20年の転移【jst・京大機械翻訳】
2019 · Hatakeyama Yukihisa, Yoshimura Sho, et al. · Respiratory Medicine Case Reports
Works count: 31
Citation count: 338
H-index: 7
I10-index: 7
Year
Topic
Type